Which Patients with localized Prostate Cancer benefit from which local Procedure and what does "benefit" mean in Prostate Cancer?

被引：0
|
作者：
Kroeze, Stephanie [1 ]
Fritz, Corinna [1 ]
Guckenberger, Matthias [1 ]
机构：
[1] Univ Spital Zurich, Dept Radiat Oncol, Ramistr 100, CH-8091 Zurich, Switzerland
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2018年 / 194卷 / 02期
关键词：
ANDROGEN DEPRIVATION THERAPY; TRIAL; RADIOTHERAPY; RADIATION; SURVIVAL;
D O I：
10.1007/s00066-017-1243-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：174 / 177
页数：4
相关论文
共 50 条
  • [21] Predicting which lung cancer patients can benefit from tivozanib
    不详
    BIOMARKERS IN MEDICINE, 2010, 4 (06) : 839 - 839
  • [22] WHICH PATIENTS WITH CLINICALLY NODE POSITIVE PROSTATE CANCER BENEFIT FROM RADICAL PROSTATECTOMY? THE IMPACT OF THE SIZE AND SITE OF NODAL INVOLVEMENT
    Gandaglia, Giorgio
    Soligo, Matteo
    Battaglia, Antonino
    Muilwijk, Tim
    Robesti, Daniele
    Capitanio, Umberto
    Tutolo, Manuela
    Gallina, Andrea
    Fossati, Nicola
    Zaffuto, Emanuele
    Moschini, Marco
    Scattoni, Vincenzo
    Joniau, Steven
    Karnes, Jeffrey R.
    Montorsi, Francesco
    Briganti, Alberto
    JOURNAL OF UROLOGY, 2018, 199 (04): : E443 - E443
  • [23] Intermediate risk localized prostate cancer: Which radiotherapeutic approach?
    Gondi, V
    Deutsch, I
    Vecchio, D
    Goluboff, E
    Ennis, RD
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 448S - 448S
  • [24] What Is the Dosimetric Benefit of Weekly and Daily Adaptive Replanning for Prostate Cancer Patients?
    Splinter, M.
    Bostel, T.
    Haering, P.
    Lang, C.
    Nicolay, N.
    MEDICAL PHYSICS, 2020, 47 (06) : E673 - E673
  • [25] Time to Benefit of Androgen Deprivation Therapy in Patients With Localized Prostate Cancer Undergoing Radiotherapy
    Wang, Jing
    Hou, Xiangwei
    Peng, Leixuan
    Dang, Yongze
    Xu, Xiangyu
    Wei, Chenyu
    Guo, Ruishan
    Song, Wenfei
    He, Chenchen
    Jiang, Jiaqi
    Li, Chao
    Han, Suxia
    JCO PRECISION ONCOLOGY, 2025, 9
  • [26] Neoadjuvant endocrine therapy of breast cancer: which patients would benefit and what are the advantages?
    Takei, Hiroyuki
    Kurosumi, Masafumi
    Yoshida, Takashi
    Hayashi, Yuji
    Higuchi, Toru
    Uchida, Sayaka
    Ninomiya, Jun
    Oba, Hanako
    Inoue, Kenichi
    Nagai, Shigenori
    Tabei, Toshio
    BREAST CANCER, 2011, 18 (02) : 85 - 91
  • [27] Neoadjuvant endocrine therapy of breast cancer: which patients would benefit and what are the advantages?
    Hiroyuki Takei
    Masafumi Kurosumi
    Takashi Yoshida
    Yuji Hayashi
    Toru Higuchi
    Sayaka Uchida
    Jun Ninomiya
    Hanako Oba
    Kenichi Inoue
    Shigenori Nagai
    Toshio Tabei
    Breast Cancer, 2011, 18 : 85 - 91
  • [28] Benefit of lycopene and tomato products for patients with prostate cancer
    Fink, Michael
    STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 (08) : 494 - 495
  • [29] HYPOFRACTIONATION: WHAT DOES IT MEAN FOR PROSTATE CANCER TREATMENT?
    Liao, Yixiang
    Joiner, Michael
    Huang, Yimei
    Burmeister, Jay
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 76 (01): : 260 - 268
  • [30] Hypofractionation: What Does It Mean For Prostate Cancer Treatment?
    Liao, Y.
    Joiner, M.
    Huang, Y.
    Burmeister, J.
    MEDICAL PHYSICS, 2008, 35 (06)
12345